Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
Blackrock Latin American Investment Trust Analyst Q&A with Edison Investment Research (LON:BRLA) 22 October 2020
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview)
Allergy Therapeutics Plc First Patient Recruited in Pivotal Phase III Birch Immunotherapy Study 16 March 2017
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
International Consolidated Airlns Grp SA 35.4% potential upside indicated by RBC Capital Markets 21 June 2024
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
Blackrock Latin American Investment Trust Analyst Q&A with Edison Investment Research (LON:BRLA) 22 October 2020
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview)
Allergy Therapeutics Plc First Patient Recruited in Pivotal Phase III Birch Immunotherapy Study 16 March 2017
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
International Consolidated Airlns Grp SA 35.4% potential upside indicated by RBC Capital Markets 21 June 2024
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
Sensata Technologies Holding plc – Consensus ‘hold’ rating and 21.0% Upside Potential 23 October 2024
Choice Hotels International, Inc. – Consensus ‘hold’ rating and -8.1% Downside Potential 23 October 2024
First Industrial Realty Trust, Inc. – Consensus ‘buy’ rating and 4.6% Upside Potential 23 October 2024
Tatton Asset Management set to grow and deliver an attractive dividend (Analyst Interview) 20 November 2020
N4 Pharma could attract a corporate partner far earlier than expected says SP Angel (Analyst Interview) 19 November 2020
Gresham House Strategic Solid 15.1% total NAV return despite covid and brexit (Interview) 17 November 2020
F&C Investment Trust plc appoints Richard Robinson as independent Non-Executive Director 27 March 2024
Moneysupermarket.com Group reports record revenue and continued strong strategic progress 19 February 2024
Tissue Regenix Analyst Q&A: Very well positioned to reach breakeven and become cash generative (LON:TRX) 29 October 2020
Tatton Asset Management Analyst Q&A: AuM 4% above Zeus Capital expectations (LON:TAM) 27 October 2020
Blackrock Latin American Investment Trust Analyst Q&A with Edison Investment Research (LON:BRLA) 22 October 2020
Allergy Therapeutics Plc First Patient Recruited in Pivotal Phase III Birch Immunotherapy Study 16 March 2017
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Global Opportunities Trust Reaffirms Successful Value and Absolute-Return Strategy (LON: GOT) 11 December 2025
Firering Strategic Minerals set to receive $1m settlement following Ricca EGM approval 12 December 2025
XPS Pensions Group (XPS.L) Investor Outlook: Navigating a 32% Potential Upside Amid Robust Analyst Confidence 12 December 2025
Vesuvius PLC (VSVS.L) Stock Analysis: A 6.15% Dividend Yield Amidst Market Challenges 12 December 2025
ZIGUP PLC ORD 50P (ZIG.L): Exploring a 25.92% Potential Upside Amidst Solid Dividend Yields 12 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a Promising 18.48% Upside 12 December 2025
